WE ARE ACEUNITY
A Life Sciences
Industry Accelerator
AceUnity is committed to accelerating high-quality innovation,
development, and delivering benefits to the Life Sciences Industry
What we do
AceUnity, specializing in conferences and media, accelerates innovation, upgrades, transformation, and sustainable development in the life sciences by creating an efficient platform for communication and value delivery. Based in China and oriented globally, AceUnity integrates diverse resources to promote technological breakthroughs, innovative therapies, and clinical progress in the life sciences industry, while embarking on a new chapter in health. The research field will cover trending fields such as cell and gene therapy, novel antibody therapies, peptide drugs, conjugated drugs, precision medicine, artificial intelligence, organoids, small molecule drugs, improved drugs，and stem cells and regenerative medicine.
Ignite Creativity, Connections and Changes in Your Business
Sciences Industry

Accelerating quality growth through

meaningful services, experiences

and delivery

Topics we
focus on
Peptide Drugs
Conjugated Drugs
Cell and Gene Therapy
Precision Medicine
Chemical Drugs
Artificial Intelligence
Recombinant Protein
Nucleic Acid Drugs
Small Molecule Drugs
Organoids
Regenerative Medicine
Antibody Therapeutics
New Drug R&D As the global pharmaceutical market evolves, new drug development faces unprecedented opportunities and challenges. To meet growing clinical demands and address complex diseases, innovative therapies including novel antibodies, cell and gene therapies, regenerative medicine, peptide drugs, conjugated drugs,small molecules, improved drugs, nucleic acid drugs, and vaccines are advancing rapidly. These therapies are critical in areas like cancer, neurological diseases, immune disorders, metabolic diseases, and rare diseases, reflecting the market’s need for safer, more effective treatments. However, challenges such as homogeneity and safety and efficacy validation persist. To overcome these, the industry must continue to innovate, refine regulatory frameworks, and enhance clinical translation to ensure that new drug development meets patient needs and fosters sustainable growth in the pharmaceutical industry.
PROCESS Drug quality is critical to life, and quality control is essential throughout the entire production process. To ensure drug quality and safety, process optimization has become a pressing need and a driving force for industrialization. The seamless transition from laboratory research to large-scale production is crucial. What are the key challenges in quality control? How can process optimization and advanced technologies overcome industrialization bottlenecks to achieve more efficient and stable production? Furthermore, strengthening supply chain management to ensure a stable supply of raw materials and continuous process optimization remains a significant challenge for companies
BT+IT The integration of AI, big data, and the pharmaceutical industry is progressing, tackling inefficiencies, low success rates, and high costs in drug development. It sets new standards for production automation and precision medicine. However, challenges like data quality, algorithm reliability, and technology transfer persist. Overcoming data silos, ensuring cross-domain collaboration, and meeting regulatory standards are key concerns. Learning from global successes in AI-driven drug discovery, clinical trial optimization, and personalized medicine can guide domestic life sciences companies. Enhancing infrastructure, developing talent, and promoting cross-industry collaboration will be essential for AI to further empower the life sciences sector.
PM Precision medicine is rapidly transforming healthcare. By utilizing advanced technologies such as in vitro diagnostics, organoids, and gene sequencing, it reveals the complexities of diseases and provides personalized treatment pathways.These technologies enable early detection and precise treatment, accelerating the transition from research to clinical application. However, widespread adoption brings challenges in implementation, data management, and process optimization. Precision medicine is poised to bring more personalized and effective healthcare solutions to patients.
RM Regenerative medicine is revolutionizing treatment methods, offering unprecedented possibilities for tissue repair and restoration. With advanced technologies like stem cell research, tissue engineering, and gene repair, it opens new pathways for treating difficult diseases. This field not only addresses challenges that traditional medicine struggles with but also provides new perspectives on long-term health management. As research advances, the key challenges lie in accelerating technology translation, ensuring the safety and efficacy of treatments, and achieving scalable applications. Regenerative medicine is poised to make a significant impact on future medical practices, bringing new hope to patient recovery.
Building strong networks leads to better outcomes for industry customers

As a leading brand of commercial events and community, AceUnity is dedicating to provide world-class platform for high-quality communication and collaboration, which includes a series of events focusing on the latest trending topics and novel therapies & disruptive technologies of next generation, and gathering industry leaders to discuss openly about new strategies for future that can inspire innovation, upgrades and transformation.

Let’s Talk

AceUnity is dedicated to becoming a catalyst for business development and barometer for the industry. It has always adhered to the 3C concepts, namely Creativity, Connection and Changes, and is committed to promoting industry momentum and resource integration to maximize commercial value.

@AceUnity All Rights Reserved